Extended-Release RANCAD in the Patients With Stable Angina Pectoris

NCT02294942 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Stable Angina Pectoris

Interventions

DRUG: RANCAD

Sponsor

TSH Biopharm Corporation Limited